Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Apr 2024 07:00 AM
RNS
Parsortix HER2 assay showcased at AACR 2024
22 Mar 2024 07:00 AM
RNS
Parsortix at European breast cancer conference
22 Jan 2024 07:00 AM
RNS
Potential utility in precision oncology
10 Jan 2024 12:57 PM
RNS
Standard form for notification of major holdings
04 Jan 2024 07:00 AM
RNS
Breakthrough clinical results
02 Jan 2024 07:00 AM
RNS
Contract announcement with Eisai Inc.
11 Dec 2023 07:00 AM
RNS
Broker Announcement
11 Dec 2023 07:00 AM
RNS
Parsortix unlocks opportunities for drug discovery
05 Dec 2023 07:00 AM
RNS
ANGLE launches Portrait+ CTC kit at SABCS
09 Nov 2023 07:00 AM
RNS
Launch of PD-L1 test to support cancer studies
09 Nov 2023 07:00 AM
RNS
Trading and business update
25 Oct 2023 07:00 AM
RNS
Supporting characterisation of CTCs in HNSCC
03 Oct 2023 07:00 AM
RNS
Parsortix outperforms standard for DTC harvest
29 Sep 2023 07:00 AM
RNS
Parsortix system showcased at ACTC conference
07 Sep 2023 07:00 AM
RNS
Interim Results for the period ended 30 June 2023
04 Sep 2023 07:00 AM
RNS
ANGLE launch of Portrait Flex assay
15 Aug 2023 07:00 AM
RNS
ANGLE notice of interim results
28 Jun 2023 04:54 PM
RNS
Result of 2023 Annual General Meeting
27 Jun 2023 12:24 PM
RNS
Standard form for notification of major holdings
05 Jun 2023 07:00 AM
RNS
ANGLE announces senior management appointments
25 May 2023 07:00 AM
RNS
Pharma services contract with Artios Pharma
22 May 2023 07:00 AM
RNS
Board change - appointment of new Chairman
02 May 2023 12:30 PM
BZW
Catalyst Health Network, Largest Network of I...
21 Apr 2023 12:04 PM
RNS
ANGLE presentation via Investor Meet Company
21 Apr 2023 12:04 PM
RNS
ANGLE presentation via Investor Meet Company
21 Apr 2023 07:00 AM
RNS
Results for the year ended 31 December 2022
21 Apr 2023 07:00 AM
RNS
Results for the year ended 31 December 2022
19 Apr 2023 07:00 AM
RNS
ANGLE announces partnership with BioView
17 Apr 2023 07:00 AM
RNS
ANGLE Parsortix poster presented at AACR 2023
13 Apr 2023 07:00 AM
RNS
Pharma Services Contract with Crescendo Biologics
03 Apr 2023 07:00 AM
RNS
Notice of Preliminary Results and Webcast
10 Mar 2023 07:00 AM
RNS
Issue of LTIP Options and Share Options
09 Mar 2023 03:03 PM
RNS
Holding(s) in Company
09 Feb 2023 02:44 PM
RNS
Director/PDMR shareholding
19 Jan 2023 07:00 AM
RNS
Appointment of Non-Executive Director
11 Jan 2023 05:20 PM
RNS
Holding(s) in Company
10 Jan 2023 06:20 PM
RNS
Holding(s) in Company
06 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
06 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
05 Jan 2023 09:05 AM
RNS
Second Price Monitoring Extn
05 Jan 2023 09:00 AM
RNS
Price Monitoring Extension
05 Jan 2023 07:01 AM
RNS
Appointment of Non-Executive Director
05 Jan 2023 07:00 AM
RNS
Business Update
12 Dec 2022 07:00 AM
RNS
Two Parsortix posters presented at SABCS
02 Dec 2022 05:30 PM
RNS
Issue of Equity
02 Nov 2022 07:00 AM
RNS
Multiple downstream analysis techniques for CTCs
01 Nov 2022 04:41 PM
RNS
Second Price Monitoring Extn
01 Nov 2022 04:35 PM
RNS
Price Monitoring Extension
24 Oct 2022 07:00 AM
RNS
Parsortix poster presented at ISLB meeting
21 Oct 2022 06:15 PM
RNS
Issue of Equity
UK 100

Latest directors dealings